| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.438 | |
| dna repair | GO:0006281 | 107 | 0.284 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.159 | |
| dna metabolic process | GO:0006259 | 303 | 0.149 | |
| chromatin modification | GO:0016568 | 187 | 0.146 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.145 | |
| response to radiation | GO:0009314 | 165 | 0.125 | |
| amine metabolic process | GO:0009308 | 45 | 0.124 | |
| chromatin organization | GO:0006325 | 206 | 0.122 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.121 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.118 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.115 | |
| double strand break repair | GO:0006302 | 48 | 0.112 | |
| dna recombination | GO:0006310 | 92 | 0.110 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.105 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.097 | |
| male meiosis | GO:0007140 | 37 | 0.097 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.093 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.086 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.085 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.082 | |
| methylation | GO:0032259 | 134 | 0.081 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.078 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.078 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.070 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.069 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.069 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.066 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.066 | |
| histone modification | GO:0016570 | 159 | 0.066 | |
| organelle fission | GO:0048285 | 170 | 0.066 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.064 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.062 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.061 | |
| histone lysine methylation | GO:0034968 | 50 | 0.060 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.059 | |
| macromolecule methylation | GO:0043414 | 120 | 0.059 | |
| protein maturation | GO:0051604 | 176 | 0.057 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.057 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.056 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.055 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.054 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.054 | |
| microtubule based process | GO:0007017 | 236 | 0.053 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.053 | |
| nuclear division | GO:0000280 | 158 | 0.051 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.049 | |
| male gamete generation | GO:0048232 | 285 | 0.049 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.049 | |
| regulation of histone modification | GO:0031056 | 56 | 0.046 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.046 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.045 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.045 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.044 | |
| protein methylation | GO:0006479 | 81 | 0.044 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.043 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.043 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.043 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.041 | |
| skeletal system development | GO:0001501 | 356 | 0.041 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.040 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.040 | |
| spermatogenesis | GO:0007283 | 284 | 0.040 | |
| b cell activation | GO:0042113 | 161 | 0.040 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.040 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.039 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.039 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.039 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.039 | |
| germ cell development | GO:0007281 | 185 | 0.039 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.039 | |
| stem cell differentiation | GO:0048863 | 268 | 0.039 | |
| oxidation reduction process | GO:0055114 | 342 | 0.038 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.037 | |
| multicellular organism growth | GO:0035264 | 161 | 0.036 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.036 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.036 | |
| double strand break repair via nonhomologous end joining | GO:0006303 | 10 | 0.036 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.036 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.036 | |
| protein alkylation | GO:0008213 | 81 | 0.035 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.035 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.035 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.034 | |
| chromosome segregation | GO:0007059 | 48 | 0.034 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.034 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.033 | |
| protein processing | GO:0016485 | 163 | 0.032 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.032 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.032 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.032 | |
| stem cell development | GO:0048864 | 219 | 0.032 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.032 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.032 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.031 | |
| organelle assembly | GO:0070925 | 177 | 0.031 | |
| regulation of cell activation | GO:0050865 | 289 | 0.031 | |
| protein ubiquitination | GO:0016567 | 171 | 0.031 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.031 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.031 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.031 | |
| cellular response to radiation | GO:0071478 | 28 | 0.030 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.030 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.030 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.030 | |
| response to light stimulus | GO:0009416 | 135 | 0.030 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.029 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.029 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.029 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.029 | |
| mitochondrion organization | GO:0007005 | 134 | 0.029 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.028 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.028 | |
| protein catabolic process | GO:0030163 | 221 | 0.028 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.028 | |
| transmembrane transport | GO:0055085 | 412 | 0.028 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.028 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.028 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.028 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.028 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.028 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.028 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.027 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.027 | |
| blastocyst development | GO:0001824 | 80 | 0.027 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.026 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.026 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.026 | |
| histone methylation | GO:0016571 | 71 | 0.026 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.026 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.026 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.026 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.026 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.026 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.026 | |
| stem cell maintenance | GO:0019827 | 130 | 0.025 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.025 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.025 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.025 | |
| inflammatory response | GO:0006954 | 244 | 0.025 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.025 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.025 | |
| action potential | GO:0001508 | 78 | 0.025 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.025 | |
| locomotory behavior | GO:0007626 | 195 | 0.025 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.025 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.024 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.024 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.023 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.023 | |
| camera type eye development | GO:0043010 | 266 | 0.023 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.023 | |
| membrane organization | GO:0061024 | 245 | 0.023 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.023 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.023 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.023 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.023 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.022 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.022 | |
| double strand break repair via homologous recombination | GO:0000724 | 21 | 0.022 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.022 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.022 | |
| cellular response to ionizing radiation | GO:0071479 | 11 | 0.022 | |
| telomere maintenance | GO:0000723 | 19 | 0.022 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.022 | |
| cation transport | GO:0006812 | 399 | 0.022 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.022 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.022 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.022 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.022 | |
| respiratory tube development | GO:0030323 | 167 | 0.022 | |
| meiosis i | GO:0007127 | 60 | 0.022 | |
| atp metabolic process | GO:0046034 | 75 | 0.022 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.022 | |
| glucose homeostasis | GO:0042593 | 128 | 0.022 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.022 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.021 | |
| regulation of protein localization | GO:0032880 | 231 | 0.021 | |
| immune effector process | GO:0002252 | 321 | 0.021 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.021 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.021 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.021 | |
| dna replication | GO:0006260 | 52 | 0.021 | |
| response to acid chemical | GO:0001101 | 111 | 0.021 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.021 | |
| negative regulation of cell division | GO:0051782 | 24 | 0.020 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.020 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.020 | |
| respiratory system development | GO:0060541 | 190 | 0.020 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.020 | |
| protein acylation | GO:0043543 | 64 | 0.020 | |
| cell division | GO:0051301 | 120 | 0.020 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.020 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.020 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.020 | |
| cellular homeostasis | GO:0019725 | 240 | 0.020 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.019 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.019 | |
| cell fate commitment | GO:0045165 | 210 | 0.019 | |
| atp catabolic process | GO:0006200 | 55 | 0.019 | |
| maintenance of location | GO:0051235 | 89 | 0.019 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.019 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.019 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.019 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.019 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.019 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.018 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.018 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.018 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.018 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.018 | |
| forebrain development | GO:0030900 | 302 | 0.018 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.018 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.018 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.018 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.018 | |
| t cell differentiation | GO:0030217 | 174 | 0.018 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.018 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.018 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.018 | |
| chromosome organization involved in meiosis | GO:0070192 | 39 | 0.018 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.018 | |
| regionalization | GO:0003002 | 337 | 0.017 | |
| sensory perception | GO:0007600 | 245 | 0.017 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.017 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.017 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.017 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.017 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.017 | |
| response to oxygen levels | GO:0070482 | 62 | 0.017 | |
| regulation of cell division | GO:0051302 | 76 | 0.017 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 36 | 0.017 | |
| protein localization to organelle | GO:0033365 | 185 | 0.017 | |
| ossification | GO:0001503 | 216 | 0.017 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.017 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.017 | |
| cognition | GO:0050890 | 149 | 0.017 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.017 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.017 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.016 | |
| compound eye development | GO:0048749 | 1 | 0.016 | |
| regulation of binding | GO:0051098 | 111 | 0.016 | |
| dna catabolic process | GO:0006308 | 19 | 0.016 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.016 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.016 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.016 | |
| learning or memory | GO:0007611 | 148 | 0.016 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.016 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.016 | |
| bone development | GO:0060348 | 120 | 0.016 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.016 | |
| connective tissue development | GO:0061448 | 179 | 0.016 | |
| response to inorganic substance | GO:0010035 | 96 | 0.016 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.016 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.016 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.016 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.016 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.016 | |
| t cell activation | GO:0042110 | 289 | 0.016 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.015 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.015 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.015 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.015 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.015 | |
| regulation of dna recombination | GO:0000018 | 34 | 0.015 | |
| reciprocal dna recombination | GO:0035825 | 16 | 0.015 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.015 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.015 | |
| response to x ray | GO:0010165 | 11 | 0.015 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.015 | |
| muscle tissue development | GO:0060537 | 308 | 0.015 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.015 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.015 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.015 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.015 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.015 | |
| spermatid differentiation | GO:0048515 | 115 | 0.015 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.015 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.015 | |
| protein oligomerization | GO:0051259 | 67 | 0.015 | |
| neural tube development | GO:0021915 | 160 | 0.015 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.015 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.015 | |
| axonogenesis | GO:0007409 | 274 | 0.015 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.015 | |
| urogenital system development | GO:0001655 | 261 | 0.015 | |
| regulation of secretion | GO:0051046 | 274 | 0.015 | |
| b cell differentiation | GO:0030183 | 78 | 0.014 | |
| histone acetylation | GO:0016573 | 41 | 0.014 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.014 | |
| response to growth factor | GO:0070848 | 198 | 0.014 | |
| cell cycle arrest | GO:0007050 | 37 | 0.014 | |
| tube formation | GO:0035148 | 140 | 0.014 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.014 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.014 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.014 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.014 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.014 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.014 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.014 | |
| somatic recombination of immunoglobulin genes involved in immune response | GO:0002204 | 36 | 0.014 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.014 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.014 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.014 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.014 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.014 | |
| cellular response to lipid | GO:0071396 | 145 | 0.014 | |
| response to peptide | GO:1901652 | 136 | 0.014 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.014 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.014 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.014 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.014 | |
| heterochromatin organization | GO:0070828 | 4 | 0.014 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.014 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.014 | |
| telencephalon development | GO:0021537 | 186 | 0.014 | |
| negative regulation of growth | GO:0045926 | 99 | 0.014 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.014 | |
| regulation of defense response | GO:0031347 | 233 | 0.014 | |
| female gamete generation | GO:0007292 | 74 | 0.014 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.014 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.014 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.014 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.013 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.013 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.013 | |
| limb development | GO:0060173 | 166 | 0.013 | |
| digestive system development | GO:0055123 | 200 | 0.013 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.013 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.013 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.013 | |
| epithelial cell development | GO:0002064 | 159 | 0.013 | |
| developmental maturation | GO:0021700 | 193 | 0.013 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.013 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.013 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.013 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.013 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.013 | |
| spermatid development | GO:0007286 | 108 | 0.013 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.013 | |
| cartilage development | GO:0051216 | 140 | 0.013 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.013 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.013 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.013 | |
| mitotic recombination | GO:0006312 | 3 | 0.013 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.013 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.013 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.013 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.012 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.012 | |
| rhythmic process | GO:0048511 | 174 | 0.012 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.012 | |
| gliogenesis | GO:0042063 | 141 | 0.012 | |
| angiogenesis | GO:0001525 | 201 | 0.012 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.012 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.012 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.012 | |
| recombinational repair | GO:0000725 | 21 | 0.012 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.012 | |
| appendage development | GO:0048736 | 166 | 0.012 | |
| nucleus organization | GO:0006997 | 45 | 0.012 | |
| ear development | GO:0043583 | 200 | 0.012 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.012 | |
| telomere maintenance in response to dna damage | GO:0043247 | 4 | 0.012 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.012 | |
| t cell proliferation | GO:0042098 | 120 | 0.012 | |
| protein targeting | GO:0006605 | 143 | 0.012 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.012 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.012 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.012 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.012 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.012 | |
| gonad development | GO:0008406 | 141 | 0.012 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.012 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.012 | |
| response to uv | GO:0009411 | 44 | 0.012 | |
| response to gamma radiation | GO:0010332 | 22 | 0.012 | |
| circadian rhythm | GO:0007623 | 114 | 0.012 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.012 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.012 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.012 | |
| pallium development | GO:0021543 | 120 | 0.012 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.012 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.012 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.012 | |
| endocytosis | GO:0006897 | 168 | 0.012 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.012 | |
| lung development | GO:0030324 | 164 | 0.012 | |
| fat cell differentiation | GO:0045444 | 160 | 0.012 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.012 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.012 | |
| gland development | GO:0048732 | 330 | 0.012 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.012 | |
| regulation of system process | GO:0044057 | 200 | 0.011 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.011 | |
| digestive tract development | GO:0048565 | 190 | 0.011 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.011 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.011 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.011 | |
| response to oxidative stress | GO:0006979 | 123 | 0.011 | |
| isotype switching | GO:0045190 | 36 | 0.011 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.011 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.011 | |
| histone h3 k36 methylation | GO:0010452 | 6 | 0.011 | |
| amide transport | GO:0042886 | 138 | 0.011 | |
| synapsis | GO:0007129 | 34 | 0.011 | |
| cellular response to peptide | GO:1901653 | 92 | 0.011 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.011 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.011 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.011 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.011 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.011 | |
| segmentation | GO:0035282 | 93 | 0.011 | |
| cytokine production | GO:0001816 | 319 | 0.011 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.011 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.011 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.011 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.011 | |
| neural tube formation | GO:0001841 | 108 | 0.011 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.011 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.011 | |
| response to drug | GO:0042493 | 75 | 0.011 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.011 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.011 | |
| endomembrane system organization | GO:0010256 | 147 | 0.011 | |
| signal transduction involved in dna damage checkpoint | GO:0072422 | 3 | 0.011 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.011 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.011 | |
| positive regulation of growth | GO:0045927 | 104 | 0.011 | |
| cation homeostasis | GO:0055080 | 212 | 0.011 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.011 | |
| nucleotide excision repair | GO:0006289 | 13 | 0.011 | |
| nuclear transport | GO:0051169 | 139 | 0.011 | |
| gene silencing | GO:0016458 | 38 | 0.011 | |
| intra s dna damage checkpoint | GO:0031573 | 4 | 0.011 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.011 | |
| striated muscle cell development | GO:0055002 | 125 | 0.011 | |
| glial cell differentiation | GO:0010001 | 131 | 0.010 | |
| zymogen activation | GO:0031638 | 41 | 0.010 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.010 | |
| protection from non homologous end joining at telomere | GO:0031848 | 4 | 0.010 | |
| protein import | GO:0017038 | 101 | 0.010 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.010 | |
| response to amino acid | GO:0043200 | 37 | 0.010 | |
| response to hypoxia | GO:0001666 | 58 | 0.010 | |
| neuronal action potential | GO:0019228 | 54 | 0.010 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.010 | |
| immunoglobulin production | GO:0002377 | 73 | 0.010 | |
| cell maturation | GO:0048469 | 127 | 0.010 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.010 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.010 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.010 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.010 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.010 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.010 | |
| response to peptide hormone | GO:0043434 | 127 | 0.010 | |
| chromosome separation | GO:0051304 | 14 | 0.010 | |
| regulation of protein stability | GO:0031647 | 52 | 0.010 | |
| lateral inhibition | GO:0046331 | 1 | 0.010 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.010 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.010 | |
